1279. Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US.

por Kuretski, Jennifer, Donovan, Cindy, Harper, Gavin, Merrill, Deanna, Mycock, Katie L, Oglesby, Alan, Metzner, Aimee, Patarroyo, Jimena
Publicado 2022

1278. Real World Treatment Experience of Single Tablet Dolutegravir/Lamivudine in Those Naïve to Treatment with Baseline Viral Loads ≥ 100,000 copies/mL in the US

por Benson, Paul, Donovan, Cindy, Harper, Gavin, Merrill, Deanna, Mycock, Katie L, Oglesby, Alan, Patarroyo, Jimena, Metzner, Aimee
Publicado 2022

1607. Clinical Outcomes at Month 6 after Initiation of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in an Observational Real-World Study (BEYOND)

por Sinclair, Gary I, Sension, Michael, Dretler, Alexandra, Schneider, Stefan, Schubert, Catherine K, Merrill, Deanna, Richardson, David, Sherif, Bintu, Zografos, Laurie, Garris, Cindy
Publicado 2023

1559. Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis into Standard of Care: Baseline Results from the PrEP Im...

por Torres, Julian A, Dandachi, Dima, Holder, Hadrian, Li, Bo, Gaudion, Alison, Merrill, Deanna, Andrae, David, Lenderking, William, Moodley, Riya, de Ruiter, Annemiek, Czarnogorski, Maggie, Pilgrim, Nanlesta
Publicado 2023

1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for P...

por Richmond, Teriya, Dunn, Michael, Bernard, Marye, Urbaityte, Rimgaile, Sutton, Kenneth, Sutherland-Phillips, Denise, Dyson, Alftan, Merrill, Deanna, Chang, Samantha, Mack, Nicole, Haley, Amber, Brown, Kimberley, Evans, Tammeka
Publicado 2023

1547. Integrating Long-acting Injectable Cabotegravir for PrEP into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex with Men: Results...

por Valenti, William M, Phoenix, John, Patel, Rupa R, Tims-Cook, Zandraetta, Pilgrim, Nanlesta, Haley, Amber, Sutton, Kenneth, Gaudion, Alison, Merrill, Deanna, Urbaityte, Rimgaile, Li, Bo, Andrae, David, Bonner, Courtney, Herbst, Abigail, Chowdhury, Dhuly, Garges, Harmony, Czarnogorski, Maggie
Publicado 2023

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

por Rolle, Charlotte-Paige, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson, Ramgopal, Moti, Leone, Peter A., Matthews, Jessica E., Dalessandro, Marybeth, Underwood, Mark R., Angelis, Konstantinos, Wynne, Brian R., Merrill, Deanna, Nguyen, Christopher, van Wyk, Jean, Zolopa, Andrew R.
Publicado 2021

75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Stu...

por Rolle, Charlotte-Paige M, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson K, Ramgopal, Moti, Jayaweera, Dushyantha, Leone, Peter, Matthews, Jessica, Cupo, Michael, Underwood, Mark, Angelis, Kostas, Wynne, Brian, Merrill, Deanna, Nguyen, Christopher T, van Wyk, Jean A, Zolopa, Andrew
Publicado 2021

Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (...

por Czarnogorski, Maggie, Garris, Cindy P., Dalessandro, Marybeth, D'Amico, Ronald, Nwafor, Toyin, Williams, Will, Merrill, Deanna, Wang, YuanYuan, Stassek, Larissa, Wohlfeiler, Michael B., Sinclair, Gary I., Mena, Leandro A., Thedinger, Blair, Flamm, Jason A., Benson, Paul, Spreen, William R.
Publicado 2022

Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementat...

por Garris, Cindy P., Czarnogorski, Maggie, Dalessandro, Marybeth, D'Amico, Ronald, Nwafor, Toyin, Williams, Will, Merrill, Deanna, Wang, YuanYuan, Stassek, Larissa, Wohlfeiler, Michael B., Sinclair, Gary I., Mena, Leandro A., Thedinger, Blair, Flamm, Jason A., Benson, Paul, Spreen, William R.
Publicado 2022

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks

por Rolle, Charlotte-Paige, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson, Ramgopal, Moti, Jayaweera, Dushyantha T, Leone, Peter A, Matthews, Jessica E, Cupo, Michael, Underwood, Mark R, Angelis, Konstantinos, Wynne, Brian R, Merrill, Deanna, Nguyen, Christopher, van Wyk, Jean, Zolopa, Andrew R
Publicado 2023